Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study

Abbonizio, F., Giampaolo, A., Arcieri, R. & Hassan, H.J. & the Associazione Italiana Centri Emofilia (AICE). (2011) Registro Nazionale delle Coagulopatie Congenite. Rapporto 2011. Rapporti ISTISAN 12/55. http://www.iss.it/binary/ publ/cont/12_55_web.pdf Binny, C., McIntosh, J., Della Peruta, M., Kymalainen, H., Tuddenham, E.G., Buckley, S.M., Waddington, S.N., McVey, J.H., Spence, Y., Morton, C.L., Trasher, A.J., Gray, J.T., Castellino, F.J., Tarantal, A.F., Davidoff, A.M. & Nathwani, A.C. (2012) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage. Blood, 119, 957–966. Borhany, M., Pahore, Z., UI Qadr, Z., Rehan, M., Khan, A., Ansari, S., Farzana, T., Nadeem, M., Raza, S.A. & Shamsi, T. (2010) Bleeding disorders in the tribe: result of consanguineous in breeding. Orphanet Journal of Rare Diseases, 5, 23. Di Minno, M.N., Dolce, A. & Mariani, G. (2013) Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thrombosis and Haemostasis, 109, 1051–1059. Farah, R.A., Hamod, D., Melick, N., Giansily-Blaizot, M. & Sallah, S. (2007) Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency. Journal of Thrombosis and Haemostasis, 5, 433–434. Giansily-Blaizot, M., Aguilar-Martinez, P., BironAndreani, C., Jeanjean, P., Igual, H. & Schved, J.F. (2001) Study Group of Factor Seven Deficiency. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. European Journal of Human Genetics, 9, 105–112. Jouannic, J.M., Tachdjian, G., Costa, J.M. & B enifla, J.L. (2008) Coelomic fluid analysis: the absolute necessity to prove its fetal origin. Reproductive Biomedicine Online, 16, 148–151. Mariani, G., Herrmann, F.H., Dolce, A., Batorova, A., Etro, D., Peyvandi Wulff, F.K., Schved, J.F., Auerswald, G., Ingerslev, J., Bernardi, F. & International Factor VII Deficiency Study Group. (2005) International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thrombosis and Haemostasis, 93, 481–487. Morfini, M., Batorova, A., Mariani, G., Auerswald, G., Bernardi, F., Di Minno, G., Dolce, A., Fede, C., Giansily-Blaizot, M., Ingerslev, J., Martinowitz, U., Napolitano, M., Pinotti, M. & Schved, J. (2014) for the International FVII (IF7) and the Seven Treatment Evaluation Registry (STER) Study Groups. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamics effect. Thrombosis and Haemostasis, 112, 424– 425. Napolitano, M., Giansily-Blaizot, M., Dolce, A., Schvend, J.F., Auerswald, G., Ingerslev, J., Bjerre, J., Altisent, C., Charoenkwan, P., Michaels, L., Chuansumrit, A., Di Minno, G., Caliskan, U. & Mariani, G. (2013) Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Hematologica, 98, 538– 544.